HIV Vaccine Trials Network

OUR GOAL A Safe and Effective Vaccine The HVTN’s mission is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV globally. To date, the Network has conducted the majority of the published, presented, or ongoing clinical trials of preventive HIV vaccines worldwide. In the process, we have gained tremendous experience in implementing an innovative global scientific organization, which combines the intellectual robustness and creativity of academia with the focus and infrastructure of industry. The HVTN is comprised of the Leadership and Operations Center (LOC), Laboratory Center (LC), Statistical and Data Management Center (SDMC), study clinics , and participants and communities. Each of these components is necessary to conduct our clinical trials. One unique advantage of the Network is the vast collection of samples and data from all studies that allows us to compare and contrast cross-study results. We can then decide which vaccine regimens are worth pursuing versus those that are not as promising. By sharing these data with other researchers, we help the entire HIV prevention effort move forward.